NYSE - Delayed Quote
USD
Nuvation Bio Inc. (NUVB)
4.7600
-0.0100
(-0.21%)
At close: October 30 at 4:00:03 PM EDT
4.7400
-0.0200
(-0.42%)
After hours: October 30 at 5:39:46 PM EDT
Trade NUVB on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutNuvation Bio is expanding its pivotal Phase 3 SIGMA study of safusidenib into six European countries. The company also has an upcoming third-quarter 2026 results update on November 4, while its approved cancer drug IBTROZI remains the main commercial asset.
